Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-20 7:43 pm Purchase | 2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 39,691,649 35.000% | 8,158,868 (+25.87%) | Filing History |
| 2024-12-17 9:52 pm Sale | 2024-10-28 | 13D | Arcus Biosciences, Inc. RCUS | ROSEN TERRY J | 3,790,875 4.100% | -501,865 (-11.69%) | Filing History |
| 2024-11-12 09:50 am Sale | 2024-11-08 | 13G | Arcus Biosciences, Inc. RCUS | FMR LLC | 4,467,557 4.886% | -261,225 (-5.52%) | Filing History |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 9,732,399 10.600% | 0 (Unchanged) | Filing History |
| 2024-10-23 5:04 pm Sale | 2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 9,732,399 10.600% | -302,771 (-3.02%) | Filing History |
| 2024-10-17 11:31 am Sale | 2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS | STATE STREET CORP STT | 3,011,174 3.300% | -1,228,403 (-28.97%) | Filing History |
| 2024-02-13 4:58 pm Purchase | 2023-12-29 | 13G | Arcus Biosciences, Inc. RCUS | VANGUARD GROUP INC | 4,680,716 6.250% | 307,539 (+7.03%) | Filing History |
| 2024-02-09 08:35 am Purchase | 2024-02-08 | 13G | Arcus Biosciences, Inc. RCUS | FMR LLC | 4,728,782 6.317% | 4,728,782 (New Position) | Filing History |
| 2024-01-31 4:58 pm Purchase | 2024-01-29 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 31,532,781 35.000% | 5,945,828 (+23.24%) | Filing History |
| 2024-01-24 07:33 am Purchase | 2023-12-31 | 13G | Arcus Biosciences, Inc. RCUS | STATE STREET CORP STT | 4,239,577 5.660% | 4,239,577 (New Position) | Filing History |
| 2024-01-23 11:52 am Purchase | 2023-12-31 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 10,035,170 13.400% | 646,122 (+6.88%) | Filing History |
| 2023-07-06 09:38 am Purchase | 2023-06-28 | 13D | Arcus Biosciences, Inc. RCUS | GILEAD SCIENCES INC. GILD | 25,586,953 35.000% | 2,863,797 (+12.60%) | Filing History |
| 2023-02-14 4:06 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | PFM Health Sciences, LP | 2,703,287 3.700% | -1,229,946 (-31.27%) | Filing History |
| 2023-02-14 11:58 am Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.200% | -1,657,428 (-41.84%) | Filing History |
| 2023-02-09 5:42 pm Sale | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | EcoR1 Capital, LLC | 0 0.000% | -5,523,358 (Position Closed) | Filing History |
| 2023-02-09 11:07 am Purchase | 2022-12-30 | 13G | Arcus Biosciences, Inc. RCUS | VANGUARD GROUP INC | 4,373,177 6.040% | 4,373,177 (New Position) | Filing History |
| 2023-01-26 08:43 am Unchanged | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 9,389,048 13.000% | 0 (Unchanged) | Filing History |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 9,389,048 13.000% | 1,421,371 (+17.84%) | Filing History |
| 2022-10-17 4:01 pm Purchase | 2022-10-06 | 13G | Arcus Biosciences, Inc. RCUS | PFM Health Sciences, LP | 3,933,233 5.500% | 502,223 (+14.64%) | Filing History |
| 2022-05-09 3:23 pm Purchase | 2022-04-30 | 13G | Arcus Biosciences, Inc. RCUS | BlackRock Inc. BLK | 7,967,677 11.100% | 3,837,748 (+92.93%) | Filing History |